• 4-Methoxychalcone-1: Research Use and Assay Design

  2026-09-24

  Explore how to evaluate 4-Methoxychalcone-1 in cell-based research without confusing compound identity with pathway evidence. A recent retinal neovascularization study offers a useful model for designing rigorous, multi-endpoint angiogenesis experiments.

• STAT3 as a Translational Control Point in Cancer

  2026-09-24

  Cucurbitacin I (JSI-124) offers a useful way to interrogate STAT3-dependent cancer phenotypes—but translational value depends on proving pathway engagement, separating it from general toxicity, and testing the mechanism in the right biological context. This article outlines a rigorous experimental strategy and considers what emerging human assembloid research can teach about model choice without implying an untested cardiac application.

• CD109 Drives Stemness and Drug Resistance in CRC

  2026-09-23

  A 2026 study identifies a CD109–LRRC8A–AKAP12–PKCα signaling axis that activates STAT3 and supports WNT-associated stemness and chemotherapy resistance in advanced colorectal cancer. Its combination of tumor-expression analyses, cellular perturbations, and mouse metastasis models points to CD109 as a candidate vulnerability, while leaving important questions about mechanism and clinical translation open.

• SW033291: From Target Engagement to Tissue Repair

  2026-09-23

  SW033291 is a potent 15-PGDH inhibitor for studying prostaglandin E2 elevation, hematopoiesis, and tissue repair. This article presents an assay-to-translation framework that separates molecular target engagement from context-dependent regenerative phenotypes.

• 15-PGDH Inhibition and Muscle Recovery During Weight Loss

  2026-09-22

  The reference study identifies 15-PGDH inhibition as a strategy to improve muscle stem cell activity, regenerated myofiber growth, and strength recovery during semaglutide-associated weight loss. In obese mice, combining a 15-PGDH inhibitor with semaglutide improved postinjury muscle quality and force without eliminating the desired reduction in body weight.

• Rational Design of IR-1061 NIR-II Liposomes

  2026-09-22

  This 2021 study shows that IR-1061 fluorescence is governed not only by the dye structure but also by liposome charge, loading level, and molecular confinement. The optimized IR1061-ALP-N3 nanosystem produced high-resolution systemic angiography and maintained vascular fluorescence for more than 16 hours in mice, offering practical design principles for NIR-II imaging formulations.

• Triiodothyronine: Reliable T3 Assay Workflows

  2026-09-21

  This scenario-based guide shows how Triiodothyronine (SKU C6407) can improve experimental control in viability, proliferation, cytotoxicity, and cellular metabolism assays. It covers interpretation of T3-driven metabolic effects, DMSO stock preparation, stability, orthogonal validation, and practical vendor-selection criteria.

• N4-Acetylcytidine as a Control for RNA Assays

  2026-09-21

  N4-Acetylcytidine is more than an RNA-modification standard: it can help researchers separate free-nucleoside metabolism from RNA-bound ac4C biology. This article develops an assay-centered framework based on recent ASCH-domain structural findings, product chemistry, and orthogonal control design.

• Astrocytic GAT-3 in Dentate Gyrus Memory

  2026-09-20

  The reference study shows that astrocytic GAT-3 converts GABA uptake into a calcium-dependent signal that enhances dentate gyrus synaptic transmission and supports contextual fear memory. Its findings distinguish transporter-mediated astrocyte signaling from canonical GABA receptor effects, providing a mechanistic framework for synaptic transmission research and future pharmacological controls.

• NMDA in Excitotoxicity and Retinal Ferroptosis

  2026-09-19

  NMDA provides a controlled receptor-level trigger for excitotoxicity research, calcium influx measurement, and oxidative-stress profiling. Its use in a retinal glaucoma model also enables practical testing of how BMP4-GPX4-associated responses relate to ferroptosis, RGC injury, and stem-cell differentiation.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Applied Workflow

  2026-09-18

  Use dual fluorescence to distinguish mRNA uptake from productive translation in macrophage and nanoparticle studies. This workflow combines Cy5 tracking, EGFP functional readouts, and practical troubleshooting for more informative gene-delivery optimization.

• Carbapenemase Gene Transmission in CREC

  2026-09-18

  This study maps carbapenemase-encoding gene localization, mobility, and strain relatedness among carbapenem-resistant Enterobacter cloacae collected from eight Guangdong teaching hospitals. Its main contribution is the integration of plasmid elimination, conjugation, antimicrobial susceptibility testing, mobile-element analysis, and ERIC-PCR to distinguish transferable resistance from clonal dissemination.

• Golgi-Tracker Green: Live-Cell Golgi Imaging

  2026-09-17

  Golgi-Tracker Green is a BODIPY FL-labeled C5-ceramide probe for selective live-cell Golgi apparatus labeling. Its photostability, lipid-based localization, and defined handling profile support Golgi apparatus imaging, lipid transport pathway visualization, and sphingolipid metabolism analysis, but the probe is not intended for fixed-cell applications.

• 2,2,2-Trichloroethanol for Protein Workflows

  2026-09-17

  2,2,2-Trichloroethanol is a flexible protein analysis reagent for in-gel visualization and modification workflows, with practical value in molecular biology research and neurobiology sample QC. This guide connects reproducible electrophoresis setup with the dopamine transporter imaging evidence of Goggi et al., while clearly separating ex vivo protein assays from in vivo functional neuroimaging.

• CSBTA Pharmacokinetics in MASH Mice

  2026-09-16

  A 2025 study integrates plasma pharmacokinetics, tissue distribution, cellular transport, microsomal metabolism, and regulatory protein expression to explain how MASH alters exposure to Corydalis saxicola Bunting total alkaloids (CSBTA). Its findings indicate that disease state and repeated dosing can increase systemic and hepatic accumulation, providing a mechanistic basis for disease-aware dose design.

8600 records 1/574 page Next 12345 下5页 Last page